Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concizumab Compassionate Use Programme for Patients With Congenital Haemophilia

NCT04921956 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04921956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04921956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concizumab Compassionate Use Programme for Patients With Congenital Haemophilia
Lead sponsor
Novo Nordisk A/S
Phase
Expanded access
Overall status
Available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

congenital haemophilia